These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23346087)

  • 1. Genetic dissection of NK cell responses.
    Moussa P; Marton J; Vidal SM; Fodil-Cornu N
    Front Immunol; 2012; 3():425. PubMed ID: 23346087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Immunodeficiency on NK Cell Maturation and Function.
    Vargas-Hernández A; Forbes LR
    Curr Allergy Asthma Rep; 2019 Jan; 19(1):2. PubMed ID: 30661124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of natural killing and in vivo tumor elimination by the Chok locus.
    Idris AH; Iizuka K; Smith HR; Scalzo AA; Yokoyama WM
    J Exp Med; 1998 Dec; 188(12):2243-56. PubMed ID: 9858511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells.
    Baratin M; Roetynck S; Pouvelle B; Lemmers C; Viebig NK; Johansson S; Bierling P; Scherf A; Gysin J; Vivier E; Ugolini S
    PLoS One; 2007 Feb; 2(2):e228. PubMed ID: 17311092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
    Tassi I; Klesney-Tait J; Colonna M
    Immunol Rev; 2006 Dec; 214():92-105. PubMed ID: 17100878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans.
    Voss M; Bryceson YT
    Clin Immunol; 2017 Apr; 177():29-42. PubMed ID: 26592356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells.
    Littwitz-Salomon E; Dittmer U; Sutter K
    Retrovirology; 2016 Nov; 13(1):77. PubMed ID: 27821119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6.
    Yokoyama WM; Ryan JC; Hunter JJ; Smith HR; Stark M; Seaman WE
    J Immunol; 1991 Nov; 147(9):3229-36. PubMed ID: 1680927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic architecture of growth traits in Populus revealed by integrated quantitative trait locus (QTL) analysis and association studies.
    Du Q; Gong C; Wang Q; Zhou D; Yang H; Pan W; Li B; Zhang D
    New Phytol; 2016 Feb; 209(3):1067-82. PubMed ID: 26499329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of natural killer cell mediated caspases activation in a graft-versus-host disease model of semiallogeneic small bowel transplantation.
    Fändrich F; Zepernick-Kalinski C; Gebhardt H; Henne-Bruns D; Zavazava N; Lin X
    Transpl Immunol; 1999 Mar; 7(1):1-7. PubMed ID: 10375071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKG2D gene variation and susceptibility to viral bronchiolitis in childhood.
    Pasanen A; Karjalainen MK; Kummola L; Waage J; Bønnelykke K; Ruotsalainen M; Piippo-Savolainen E; Goksör E; Nuolivirta K; Chawes B; Vissing N; Bisgaard H; Jartti T; Wennergren G; Junttila I; Hallman M; Korppi M; Rämet M
    Pediatr Res; 2018 Sep; 84(3):451-457. PubMed ID: 29967528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural selection for killer receptors and their MHC class I ligands: In pursuit of gene pairs that fit well in tandem.
    Brown MG; Gamache A; Nash WT; Cronk J
    J Leukoc Biol; 2019 Mar; 105(3):489-495. PubMed ID: 30500089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
    Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host genetic control of natural killer cell diversity revealed in the Collaborative Cross.
    Dupont MSJ; Guillemot V; Campagne P; Serafini N; Marie S; Montagutelli X; Di Santo JP; Vosshenrich CAJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
    Bonavida B; Wright SC
    J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shaping of Natural Killer Cell Antitumor Activity by
    Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
    Front Immunol; 2017; 8():458. PubMed ID: 28491060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of Natural Killer Cells in Human Health, Disease, and Survival.
    Parham P; Guethlein LA
    Annu Rev Immunol; 2018 Apr; 36():519-548. PubMed ID: 29394121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology and clinical impact of human natural killer cells.
    Farag SS; VanDeusen JB; Fehniger TA; Caligiuri MA
    Int J Hematol; 2003 Jul; 78(1):7-17. PubMed ID: 12894845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.